Aerobic Exercise as an Essential Component of Non-Pharmacological Management for Metabolic Syndrome - A Review
DOI:
https://doi.org/10.12775/QS.2026.50.67623Keywords
Metabolic Syndrome, Aerobic Exercise, Insulin Resistance, Dyslipidemia, Exercise Prescription, Diabetes Mellitus type 2Abstract
Background. Metabolic Syndrome (MetS) is a prevalent cluster of conditions that significantly increases the risk of cardiovascular disease and type 2 diabetes mellitus. Lifestyle modification is universally recognized as the primary therapeutic strategy, with aerobic exercise playing a crucial role in improving metabolic health and reducing mortality risks in affected populations.
Aim. This review synthesizes current evidence on the efficacy and mechanisms of aerobic exercise as a fundamental non-pharmacological strategy for managing Metabolic Syndrome (MetS).
Material and methods. A search of major databases (2015–2025) was performed, focusing on systematic reviews and RCTs. Keywords included "Metabolic Syndrome," "aerobic exercise," "insulin resistance," "dyslipidemia," and "exercise prescription."
Results. Regular aerobic exercise improves cardiometabolic risk factors independently of significant weight loss. It enhances insulin sensitivity via GLUT4 translocation, optimizes the lipid profile (reducing triglycerides, increasing HDL), and reduces visceral adiposity and inflammation. Additionally, High-Intensity Interval Training (HIIT) is highlighted as a potent strategy, often offering superior efficacy to moderate-intensity continuous training (MICT).
Conclusions. Aerobic exercise is an essential component of MetS management. Professionals should prioritize individualized prescriptions, incorporating both MICT and HIIT, to effectively mitigate cardiometabolic risk and improve patient health.
References
1. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645. doi:10.1161/CIRCULATIONAHA.109.192644
2. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735-2752. doi:10.1161/CIRCULATIONAHA.105.169404
3. American College of Sports Medicine (ACSM). (2018). ACSM's Guidelines for Exercise Testing and Prescription (10th ed.). Wolters Kluwer.
4. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. doi:10.1056/NEJMoa012512
5. Bassi N, Karagodin I, Wang S, et al. Lifestyle modification for metabolic syndrome: a systematic review. Am J Med. 2014;127(12):. doi:10.1016/j.amjmed.2014.06.035
6. Golbidi S, Mesdaghinia A, Laher I. Exercise in the metabolic syndrome. Oxid Med Cell Longev. 2012;2012:349710. doi:10.1155/2012/349710
7. ElSayed NA, Aleppo G, Aroda VR, et al. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S254-S266. doi:10.2337/dc23-S015
8. Slentz CA, Bateman LA, Willis LH, et al. Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT. Am J Physiol Endocrinol Metab. 2011;301(5):E1033-E1039. doi:10.1152/ajpendo.00291.2011
9. Colberg SR, Sigal RJ, Yardley JE, et al. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065-2079. doi:10.2337/dc16-1728
10. da Silva CA, Ribeiro JP, Canto JC, et al. High-intensity aerobic training improves endothelium-dependent vasodilation in patients with metabolic syndrome and type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012;95(2):237-245. doi:10.1016/j.diabres.2011.09.034
11. Li N, Shi H, Guo Q, et al. Aerobic Exercise Prevents Chronic Inflammation and Insulin Resistance in Skeletal Muscle of High-Fat Diet Mice. Nutrients. 2022;14(18):3730. Published 2022 Sep 10. doi:10.3390/nu14183730
12. Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med. 2014;44(2):211-221. doi:10.1007/s40279-013-0110-5
13. Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347(19):1483-1492. doi:10.1056/NEJMoa020194
14. Ross R, Soni S, Houle SA. Negative Energy Balance Induced by Exercise or Diet: Effects on Visceral Adipose Tissue and Liver Fat. Nutrients. 2020;12(4):891. Published 2020 Mar 25. doi:10.3390/nu12040891
15. Ohkawara K, Tanaka S, Miyachi M, Ishikawa-Takata K, Tabata I. A dose-response relation between aerobic exercise and visceral fat reduction: systematic review of clinical trials. Int J Obes (Lond). 2007;31(12):1786-1797. doi:10.1038/sj.ijo.0803683
16. Warburton DER, Bredin SSD. Health benefits of physical activity: a systematic review of current systematic reviews. Curr Opin Cardiol. 2017;32(5):541-556. doi:10.1097/HCO.0000000000000437
17. Guo J, Lou Y, Zhang X, Song Y. Effect of aerobic exercise training on cardiometabolic risk factors among professional athletes in the heaviest-weight class. Diabetol Metab Syndr. 2015;7:78. Published 2015 Sep 17. doi:10.1186/s13098-015-0071-y
18. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709-2716. doi:10.1001/jama.288.21.2709
19. Wewege M, van den Berg R, Ward RE, Keech A. The effects of high-intensity interval training vs. moderate-intensity continuous training on body composition in overweight and obese adults: a systematic review and meta-analysis. Obes Rev. 2017;18(6):635-646. doi:10.1111/obr.12532
20. Boutcher SH. High-intensity intermittent exercise and fat loss. J Obes. 2011;2011:868305. doi:10.1155/2011/868305
21. Creviston T, Quinn L. Exercise and physical activity in the treatment of type 2 diabetes. Nurs Clin North Am. 2001;36(2):243-vi.
22. Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25 Suppl 3:1-72. doi:10.1111/sms.12581
23. Wilson JM, Marin PJ, Rhea MR, Wilson SM, Loenneke JP, Anderson JC. Concurrent training: a meta-analysis examining interference of aerobic and resistance exercises. J Strength Cond Res. 2012;26(8):2293-2307. doi:10.1519/JSC.0b013e31823a3e2d
24. Edwards JJ, Griffiths M, Deenmamode AHP, O'Driscoll JM. High-Intensity Interval Training and Cardiometabolic Health in the General Population: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Sports Med. 2023;53(9):1753-1763. doi:10.1007/s40279-023-01863-8
25. Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):873-934. doi:10.1161/CIR.0b013e31829b5b44
26. Chudyk A, Petrella RJ. Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis. Diabetes Care. 2011;34(5):1228-1237. doi:10.2337/dc10-1881
27. Wasserman, K. (1994). The Anaerobic Threshold: Definition, Physiological Significance and Clinical Use. Chest, 105(4), S11–S18.
28. Vina J, Sanchis-Gomar F, Martinez-Bello V, Gomez-Cabrera MC. Exercise acts as a drug; the pharmacological benefits of exercise. Br J Pharmacol. 2012;167(1):1-12. doi:10.1111/j.1476-5381.2012.01970.x
29. Khater A, Al-Badri M, Salah T, Dhaver SE, Kibaa K, Hamdy O. Long-Term Effects of Intensive Lifestyle Intervention on Cardiometabolic Outcomes in Patients With Diabetes in Real-World Clinical Practice: A 15-Year Longitudinal Study. J Diabetes. 2025;17(11):e70153. doi:10.1111/1753-0407.70153
30. Gharipour M, Nezafati P, Sadeghian L, Eftekhari A, Rothenberg I, Jahanfar S. Precision medicine and metabolic syndrome. ARYA Atheroscler. 2022;18(4):1-10. doi:10.22122/arya.2022.26215
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Marzena Swojnóg, Magdalena Barczewska, Dominika Bieszczad, Barbara Reizer, Zofia Botto, Patrycja Felisiak, Dominika Kowalczyk, Zofia Śliwa, Dominik Andrzej Ślazyk, Klaudia Krystek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 7
Number of citations: 0
